Lipoprotein(a) [Lp(a)] has become a major focus within cardiovascular medicine due to its strong genetic basis and substantial contribution to residual cardiovascular risk. Elevated Lp(a) is highly prevalent—affecting approximately one in five individuals globally—and is increasingly recognized as a causal, inherited risk enhancer for atherosclerot